Candel Therapeutics (CADL) Non Operating Income: 2020-2024
Historic Non Operating Income for Candel Therapeutics (CADL) over the last 5 years, with Dec 2024 value amounting to -$21.8 million.
- Candel Therapeutics' Non Operating Income fell 125.75% to -$777,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $452,000, marking a year-over-year decrease of 97.16%. This contributed to the annual value of -$21.8 million for FY2024, which is 4924.34% down from last year.
- According to the latest figures from FY2024, Candel Therapeutics' Non Operating Income is -$21.8 million, which was down 4,924.34% from $452,000 recorded in FY2023.
- In the past 5 years, Candel Therapeutics' Non Operating Income ranged from a high of $15.9 million in FY2022 and a low of -$21.8 million during FY2024.
- Over the past 3 years, Candel Therapeutics' median Non Operating Income value was $452,000 (recorded in 2023), while the average stood at -$1.8 million.
- As far as peak fluctuations go, Candel Therapeutics' Non Operating Income spiked by 253.18% in 2022, and later slumped by 4,924.34% in 2024.
- Candel Therapeutics' Non Operating Income (Yearly) stood at -$3.9 million in 2020, then slumped by 168.68% to -$10.4 million in 2021, then skyrocketed by 253.18% to $15.9 million in 2022, then slumped by 97.16% to $452,000 in 2023, then tumbled by 4,924.34% to -$21.8 million in 2024.